A soluble activator that favors the ex vivo expansion of CD8+CD27+ T cells.

JCI Insight
Esther I MatusJean Gariépy

Abstract

Adoptive cell therapy involves the infusion of tumor-reactive T cells into patients with cancer to provide antitumor immunity. The ex vivo expansion and differentiation of such T cells are key parameters that affect their therapeutic potential. Human T cells are presently expanded in culture through the use of anti-CD3 and anti-CD28 mAbs immobilized on beads, expressed on cells, or assembled in the context of soluble antibody complexes. Here we report the design of a small, bispecific single-chain variable fragment construct agonizing both CD3 and CD28 pathways. This soluble T cell expansion protein, termed T-CEP, activates, expands, and differentiates human T cells ex vivo at concentrations in the femtomolar range. Importantly, T-CEP promotes the preferential growth of human CD8+ T cells over the course of 12 days in comparison with methods involving immobilized anti-CD3 mAb/soluble anti-CD28 mAb or soluble anti-CD3/CD28 mAb complexes. The differentiation profile of the resulting human T cell population is also singularly affected by T-CEP, favoring the expansion of a preferred CD8+CD27+ T cell phenotype. The activity profile of T-CEP on human T cells ex vivo suggests its use in generating human T cell populations that are mor...Continue Reading

References

Nov 14, 1997·The Journal of Experimental Medicine·D HamannR A van Lier
Feb 2, 2002·The Journal of Immunology : Official Journal of the American Association of Immunologists·Kathryn E FouldsHao Shen
Oct 18, 2002·European Journal of Immunology·Nicola BortolettoAntonio Lanzavecchia
Mar 8, 2005·The Journal of Immunology : Official Journal of the American Association of Immunologists·Francesca GiannoniSalvatore Albani
May 12, 2005·Current Opinion in Immunology·Antonio Lanzavecchia, Federica Sallusto
Jun 28, 2005·Proceedings of the National Academy of Sciences of the United States of America·Christopher A KlebanoffNicholas P Restifo
Nov 8, 2005·The Journal of Immunology : Official Journal of the American Association of Immunologists·Ruth D FritschPeter E Lipsky
Jun 6, 2006·The Journal of Immunology : Official Journal of the American Association of Immunologists·Jianping HuangPaul F Robbins
Mar 21, 2008·Nature Reviews. Cancer·Steven A RosenbergMark E Dudley
Jan 10, 2009·Annual Review of Immunology·Jennifer E Smith-GarvinMartha S Jordan
Apr 19, 2011·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Steven A RosenbergMark E Dudley
Jun 10, 2011·Science Signaling·Omer DushekP Anton van der Merwe
Jul 27, 2011·The Journal of Immunology : Official Journal of the American Association of Immunologists·Diletta Di MitriArne N Akbar
Feb 22, 2012·Biophysical Journal·Edward JudokusumoLance C Kam
Jun 27, 2012·The Journal of Immunology : Official Journal of the American Association of Immunologists·Roddy S O'ConnorMichael C Milone
Sep 22, 2012·Nature Reviews. Cancer·Luca GattinoniNicholas P Restifo
Oct 3, 2012·Advanced Drug Delivery Reviews·Xiaoying ChenWei-Chiang Shen
Oct 24, 2012·Journal of Immunotherapy·Christopher A KlebanoffNicholas P Restifo
Oct 1, 2013·Cancer Control : Journal of the Moffitt Cancer Center·Giao Q Phan, Steven A Rosenberg
Oct 15, 2013·Cytometry. Part a : the Journal of the International Society for Analytical Cytology·Anis Larbi, Tamas Fulop
Nov 22, 2013·European Journal of Immunology·Yolanda D MahnkeEnrico Lugli
Dec 18, 2013·Immunological Reviews·Joseph G CromptonNicholas P Restifo
Mar 19, 2014·The Journal of Immunology : Official Journal of the American Association of Immunologists·Hannah RabensteinReinhard Obst
Sep 7, 2018·Seminars in Immunopathology·Özcan MetInge Marie Svane
Mar 22, 2019·The Journal of Clinical Investigation·Adam D CohenMichael C Milone
Jul 30, 2019·Cancer Letters·Xiaotao JiangSha Wu
Oct 18, 2019·Clinical Pharmacology and Therapeutics·Sarah A Holstein, Matthew A Lunning
Oct 23, 2019·Signal Transduction and Targeted Therapy·Dan LiWei Wang
Sep 20, 2020·Signal Transduction and Targeted Therapy·Dan LiWei Wang

❮ Previous
Next ❯

Methods Mentioned

BETA
surface plasmon resonance
enzyme-linked immunosorbent assay
ELISA
flow cytometry
chips
chip

Software Mentioned

ProtParam
Biacore T200

Related Concepts

Related Feeds

Cancer Biology: Molecular Imaging

Molecular imaging enables noninvasive imaging of key molecules that are crucial to tumor biology. Discover the latest research in molecular imaging in cancer biology in this feed.